IL96575A - Regulation that depends on the cell cycle of the phosphorylation of a human retinoblastoma gene product - Google Patents

Regulation that depends on the cell cycle of the phosphorylation of a human retinoblastoma gene product

Info

Publication number
IL96575A
IL96575A IL9657590A IL9657590A IL96575A IL 96575 A IL96575 A IL 96575A IL 9657590 A IL9657590 A IL 9657590A IL 9657590 A IL9657590 A IL 9657590A IL 96575 A IL96575 A IL 96575A
Authority
IL
Israel
Prior art keywords
protein
phosphorylation
cells
cell
treatment
Prior art date
Application number
IL9657590A
Other languages
English (en)
Hebrew (he)
Other versions
IL96575A0 (en
Original Assignee
Canji Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canji Inc filed Critical Canji Inc
Publication of IL96575A0 publication Critical patent/IL96575A0/xx
Publication of IL96575A publication Critical patent/IL96575A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/22—Testing for sterility conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Luminescent Compositions (AREA)
IL9657590A 1989-12-07 1990-12-06 Regulation that depends on the cell cycle of the phosphorylation of a human retinoblastoma gene product IL96575A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44728289A 1989-12-07 1989-12-07

Publications (2)

Publication Number Publication Date
IL96575A0 IL96575A0 (en) 1991-09-16
IL96575A true IL96575A (en) 1995-05-26

Family

ID=23775728

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9657590A IL96575A (en) 1989-12-07 1990-12-06 Regulation that depends on the cell cycle of the phosphorylation of a human retinoblastoma gene product

Country Status (17)

Country Link
EP (1) EP0504289B1 (pt)
JP (1) JP3080402B2 (pt)
KR (1) KR100203959B1 (pt)
CN (1) CN1052607A (pt)
AT (1) ATE184653T1 (pt)
AU (1) AU653142B2 (pt)
CA (1) CA2070660A1 (pt)
DE (1) DE69033289T2 (pt)
ES (1) ES2135390T3 (pt)
FI (1) FI922615A (pt)
IE (1) IE904400A1 (pt)
IL (1) IL96575A (pt)
NO (1) NO922168L (pt)
NZ (1) NZ236391A (pt)
PT (1) PT96110A (pt)
WO (1) WO1991009114A1 (pt)
ZA (1) ZA909755B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223842B1 (en) 1986-08-11 2007-05-29 Massachusetts Eye And Ear Infirmary Detection of proteins whose absence is associated with a neoplasm
US7384735B1 (en) 1986-08-11 2008-06-10 Massachusetts Eye And Ear Infirmary Retinoblastoma nucleic acids
US5851991A (en) * 1987-08-31 1998-12-22 The Regents Of The University Of California Therapeutic use of the retinoblastoma susceptibility gene product
US7105156B1 (en) 1987-09-17 2006-09-12 The Regents Of The University Of California Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells
TW346397B (en) * 1991-10-17 1998-12-01 Univ California Cell cycle controlling compositions and methods of using same
ZA946595B (en) * 1993-09-03 1996-02-28 Res Dev Foundation Mutants of the retinoblastoma and P53 genes and uses thereof
US5969120A (en) * 1993-09-03 1999-10-19 Research Development Foundation Mutants of the RB and P53 genes
GB9506050D0 (en) 1995-03-24 1995-05-10 Osteometer A S Assaying collagen fragments in body fluids
DE69520111T2 (de) 1994-10-17 2001-09-06 Osteometer Biotech As Herlev Schätzung des Fragmentierungsmusters von Kollagen in Körperflüssigkeiten und Diagnose von mit dem Kollagenmetabolismus zusammenhängenden Störungen
AU4502096A (en) * 1994-11-11 1996-06-06 Arch Development Corporation A process of inhibiting non-neoplastic pathological cell proliferation
US6107047A (en) * 1996-03-21 2000-08-22 Osteometer Biotech A/S Assaying protein fragments in body fluids
GB9617616D0 (en) 1996-08-22 1996-10-02 Osteometer Biotech As Assaying protein fragments in body fluids
WO1998026286A2 (en) 1996-12-09 1998-06-18 Osteometer Biotech A/S Sandwich assays for collagen type i fragments
US6117646A (en) * 1997-09-22 2000-09-12 Osteometer Biotech A/S Assaying protein fragments in body fluids
JP6142068B1 (ja) * 2016-12-13 2017-06-07 株式会社マスダック サンドウィッチパンケーキ製造装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5888801A (ja) * 1981-11-20 1983-05-27 Hitachi Ltd 磁気デイスク記憶装置
US4694023A (en) * 1982-06-28 1987-09-15 Usv Pharmaceutical Corporation Alpha-alkyl polyolefinic carboxylic acids and derivatives thereof useful in the treatment of psoriasis and allergic responses
US4797762A (en) * 1987-09-22 1989-01-10 Micropolis Corporation Stress free winchester drive shaft mounting

Also Published As

Publication number Publication date
JP3080402B2 (ja) 2000-08-28
DE69033289T2 (de) 2000-01-05
NO922168D0 (no) 1992-06-01
NO922168L (no) 1992-07-15
EP0504289B1 (en) 1999-09-15
JPH05503421A (ja) 1993-06-10
ATE184653T1 (de) 1999-10-15
CN1052607A (zh) 1991-07-03
PT96110A (pt) 1991-09-30
FI922615A0 (fi) 1992-06-05
WO1991009114A1 (en) 1991-06-27
ZA909755B (en) 1991-09-25
ES2135390T3 (es) 1999-11-01
NZ236391A (en) 2001-07-27
IL96575A0 (en) 1991-09-16
EP0504289A4 (en) 1993-03-31
EP0504289A1 (en) 1992-09-23
AU653142B2 (en) 1994-09-22
AU7038991A (en) 1991-07-18
KR100203959B1 (ko) 1999-06-15
DE69033289D1 (de) 1999-10-21
FI922615A (fi) 1992-06-05
IE904400A1 (en) 1991-06-19
CA2070660A1 (en) 1991-06-08

Similar Documents

Publication Publication Date Title
Mihara et al. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product
AU653142B2 (en) Cell-cycle-dependent regulation of phosphorylation of human retinoblastoma gene product
Hanada et al. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells
Fukutomi et al. Hepatitis C virus core protein stimulates hepatocyte growth: Correlation with upregulation of wnt‐1 expression
Rickheim et al. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation
Wilson et al. pp60c-src tyrosine kinase, myristylation, and modulatory domains are required for enhanced mitogenic responsiveness to epidermal growth factor seen in cells overexpressing c-src
Sheard et al. Up‐regulation of Fas (CD95) in human p53wild‐type cancer cells treated with ionizing radiation
Long et al. Regulation of megakaryocyte phenotype in human erythroleukemia cells.
Graf et al. Characterization of the hematopoietic target cells of AEV, MC29 and AMV avian leukemia viruses
Waneck et al. Abelson leukemia virus induces lymphoid and erythroid colonies in infected fetal cell cultures
Gee et al. Differentiation of myeloid cells is accompanied by increased levels of pp60c-src protein and kinase activity.
Sanford et al. Search for “indicators” of neoplastic conversion in vitro
Tennant et al. Requirement of cellular synthesis for Kilham rat virus replication
DE69031830T2 (de) Hemmung der transformation der zellen mit erhöhter purin-metabolischer enzymaktivität
Shatkin et al. Deoxyribonucleic acid synthesis in vaccinia virus-infected HeLa cells
Nadal Synchronization of baby rat hepatocytes: a new test for the detection of factors controlling DNA synthesis in rat hepatic cells
Zhang et al. Targeted deletion of mouse Rad1 leads to deficient cellular DNA damage responses
Hulanicka et al. Induction of tubuloreticular inclusions in human lymphoma cells (Raji line) related to S-phase treatment with halogenated pyrimidines
Kenigsberg et al. Effects of basic fibroblast growth factor on the differentiation, growth, and viability of a new human medulloblastoma cell line (UM-MB1).
Raptis et al. Protein kinase C promotes the phosphorylation of immunoprecipitated middle T antigen from polyoma-transformed cells
LOCK et al. Responses of HELA and Chinese-hamster ovary p34 (cdc2)/cyclin-b kinase in relation to cell-cycle perturbations induced by etoposide
PILLAIRE et al. Regulation by transforming growth factor-β1 of G1 cyclin-dependent kinases in human retinal epithelial cells
US7056908B2 (en) Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors
US6566399B2 (en) Inhibitor of replicative senescence of human keratinocytes containing retinoic acid as active ingredients
Magun et al. Regulation of DNA replication by serum and the transforming function in cultured rat fibroblasts transformed by Rous sarcoma virus

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees